Development and In Vitro Evaluation of High Molecular Weight Chitosan Based Polymeric Composites for Controlled Delivery of Valsartan

  • Muhammad Sohail
  • , Mahmood Ahmad
  • , Muhammad Usman Minhas
  • , Haroon Rashid
  • , Ikrima Khalid

Research output: Contribution to journalArticlepeer-review

18 Citations (Scopus)

Abstract

The purpose of present study was to develop chemically cross-linked chitosan-co-poly(AMPS) hydrogel for pH-responsive and controlled delivery of valsartan. Hydrogels were synthesized using the free radical polymerization technique. A polymer (high molecular weight chitosan) was chemically cross-linked with monomer (2-acrylamido-2-methylpropane sulfonic acid (AMPS)) in aqueous medium. NʹNʹ-Methylenebisacrylamide was used as a cross-linker. Sodium hydrogen sulfite and ammonium peroxodisulfate were used as initiators. Drug loading was performed with valsartan as a model drug. Characterization of hydrogels was performed by SEM, FTIR, and DSC. Hydrogels were evaluated for pH-responsive behavior by the equilibrium swelling ratio and swelling dynamics at low and high pH. The developed cross-linked network showed pH-dependent drug release characteristics. Maximum swelling, drug loading, and release have been observed at pH 7.4. It is concluded that highly stable chitosan and AMPS-based polymeric matrices are developed. These polymeric matrices have potential to be used as a carrier for controlled delivery of valsartan.

Original languageEnglish (UK)
Pages (from-to)361-368
Number of pages8
JournalAdvances in Polymer Technology
Volume35
Issue number4
DOIs
Publication statusPublished - 1 Dec 2016
Externally publishedYes

Keywords

  • Chitosan
  • Drug Delivery Systems
  • Hydrogel
  • pH responsive
  • Swelling
  • Valsartan

Fingerprint

Dive into the research topics of 'Development and In Vitro Evaluation of High Molecular Weight Chitosan Based Polymeric Composites for Controlled Delivery of Valsartan'. Together they form a unique fingerprint.

Cite this